Please upgrade your browser.
When Scott Shirley launched Uplifting Athletes in 2007, the nonprofit operated in the basement of his mother’s Enola home.
Just because there is a treatment out there, doesn’t mean that that treatment is good for everyone...
Paracrine communication between different parts of the renal tubule is increasingly recognized as an important determinant of renal function.
Investigators in The Cancer Genome Atlas (TCGA) Research Network have uncovered a connection between how tumor cells use energy from metabolic processes and the aggressiveness of the most common form of kidney cancer...
We recently polled the more than 67,000 members of our Facebook community about the Affordable Care Act.
Unfavorable views of the law still outnumber favorable ones by a substantial margin.
WSJ: Employee Benefit Research Institute CEO Dallas Salisbury says health care costs - not income - is the ticking time bomb for American retirees, saying "the long term care private insurance market is essentially collapsing."
By Michael B. Lawing
microRNA assay determined reasonable and necessary for providing an important niche in pathologic diagnoses of Cancer of Unknown Primary.
The FDA has approved more than 30 molecularly targeted agents in cancer in recent years, including prominent examples such as trastuzumab for breast cancer, sunitinib for renal cell cancer and bevacizumab for colorectal, non-small cell lung and renal cell cancers.
|Powered by NeonCRM|